Peer Review History
Original SubmissionAugust 23, 2021 |
---|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-21-27051Non-local validated parametrization of an agent-based model of local-scale Taenia solium transmission in North-West PeruPLOS ONE Dear Dr. Pizzitutti, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Could the authors address the points raised by the reviewers, giving special attention for the comments regarding the methodology used in the study and the clarity of the text. Please submit your revised manuscript by Aug 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcello Otake Sato, Ph.D., D.V.M. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records/samples used to for validation and calibration of your model. Specifically, please ensure that you have discussed whether all data/samples were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data/samples from their medical records used in research, please include this information. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: "This study was funded by the US National Institutes of Health National Institute of Allergy and Infectious Diseases, grant number NIH R01AI141554." Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 6. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).’ 7. One of the noted authors is a group or consortium 'Cysticercosis Working Group'. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address. 8. Please ensure that you refer to Figures 1, 2, 3, 6 and 7 in your text as, if accepted, production will need this reference to link the reader to the figure. 9. Please upload a new copy of Figure 3 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ Additional Editor Comments (if provided): First of all, my apologies for the time taken for reviewing the MS. It was a really difficult task to find suitable reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper represents potentially an important step in developing a transferrable T. solium transmission model, however I have several major comments/clarifications to raise, as the manuscript is hard to follow (particularly the results) in the present form, and some important questions regarding the methodology. See attached PDF for full comments. Reviewer #2: In this paper the authors presented an new agent based model of local-scale T. solium and a new, non-local, approach to the model calibration to fit model outputs to observed human taeniasis and pig cysticercosis prevalence. The findings of the authors showed that the modeling in-silico approach may be applied in other endemic areas which is quite interesting. I believe that their modeling design is sound and logical. I would like to ask the authors to please check Lines 148, 244, 329, 546 (ERROR! Reference source not found) ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
PONE-D-21-27051R1Non-local validated parametrization of an agent-based model of local-scale Taenia solium transmission in North-West PeruPLOS ONE Dear Dr. Pizzitutti, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Dear authors, please address the comments made by the Reviewer 1. ============================== Please submit your revised manuscript by Oct 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcello Otake Sato, Ph.D., D.V.M. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear authors, please address the comments made by the reviewer 1. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I provide follow-up comments below Methods Comment 1. What about seasonal differences in transmission (if influenced by the dry or 3-month rainy season indicated by the authors on lines 137-138). For example, Braae et al. 2014 found higher probability of free-ranging in the dry season compared to wet season and therefore different exposure risk (also possibly perturbing stable endemic transmission dynamics which most models currently assume). This study reflects the situation in Tanzania, a different endemic system, but may be relevant for this system. Ref: Braae, U.C., Magnussen, P., Lekule, F. et al. Temporal fluctuations in the sero-prevalence of Taenia solium cysticercosis in pigs in Mbeya Region, Tanzania. Parasites Vectors 7, 574 (2014). https://doi.org/10.1186/s13071-014-0574-7 Authors answer: We agree. Seasonal differences are indeed important and, when possible, must be included in the model. Unfortunately, for the area under study, we have no data about seasonal changes of pig roaming areas (see ref 14). Other, possibly relevant changes in pork meat consumption can be connected for example with holydays and other social gatherings but also in this case no data are available. We deigned further studies to collect data on those topics that will be conducted in northern Peruvian rural areas. Reviewer response: Thank you, it would be useful to include comment in the discussion on the potential role of seasonal dynamics, especially around changing pork consumption practices associated with holidays etc. Lightowlers & Donadeu 2017 also mention the importance of a “pork consumption calender”, so referencing this within the specific context of Northern Peru / development of the model would be really beneficial for the reader. Comment 2. The authors mention in lines 139 – 140 that “latrines…are often of poor quality and readily accessible by humans”. This seems like an important feature of this particular endemic system, so was information on latrine quality collected (alongside information on presence of latrine & adherence; line 158 & mapped on Fig 1) and incorporated into the model? Or do the authors assume that all latrines are of equally poor quality and therefore uniformly provide an exposure risk to free-roaming pigs? If the latter (this seems the case, given lines 290-291 “The level of contamination of the defecation site depends on the presence of a latrine in the tapeworm carrier household and on adherence to its use”), this should be explicitly stated in the assumptions. 2 Authors answer: No information about latrines quality was collected during the field trial used to inform the model. We changed the text after lines 290 -291 to explain this better. Reviewer response: Thank you for this additional information and text in the manuscript. So, you assumed all households had latrines in the “good state” based on the household census or you assumed this was the case? Comment 4. The authors state new human agents are “periodically introduced” into the simulation (lines 192 – 193), with the rich dataset acquired through this study, would it not be feasible (and more realistic) to accurately simulate immigration introductions (for example are there differential rates during dry vs rainy seasons)? Authors answer: Unfortunately, no data are available about human movements in the villages under study during the study period. For that reason, only rates from obtained from neighboring areas and from the entire Piura region were used un the study. No data about seasonal differences in human movements were available. Reviewer response: Thank you, it would be useful for the authors to explicity state that human movement data was not available for the specific villages therefore migration rates were utilised from neighbouring areas (under the assumption that the rates are similar across villages in the Piura area?. Comment 5. “cysts being distributed randomly to the pork portions” (lines 201-202) is a strong assumption to include, there is good knowledge now on the carcass distribution of cysts (see Chembensofu et al. 2017), so could the authors indicate whether they have considered modelling this (assuming pork portions can be from different parts of the pig carcass?). The authors further state on lines 253 – 254 that “If the slaughtered pig is infected with T. solium, its cysts are distributed randomly to portions that are made of muscle, bones, and skin, but not to portions from entrails”; can the authors also explain here why cysts are not distributed to entrails (or a fuller description of what constitutes entrails would eb useful). Ref: Chembensofu, M., Mwape, K.E., Van Damme, I. et al. Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs. Parasites Vectors 10, 572 (2017). https://doi.org/10.1186/s13071-017-2520-y Authors answer: We totally agree: different part of the carcass present generally different cyst densities. However, this strong assumption is justified for two reasons: first in the villages under study carcass are divided into portions at home without following any predefined meat cut patterns. The second reason justifying our assumption is that even if the right distribution of cysts in different carcass parts were followed, we have no data to connecting consumption patterns and the individual characteristics of humans in the villages. The portions of pork containing different densities of cysts would be then distributed randomly to the villagers (following the geographical criteria indicated in the manuscript) resulting in no practical effect on transmission. We based our assumption of no cysts in the entrails (it is now specified in the text that entrails are: liver, spleen, lungs and intestines) on papers like: Boa ME, Kassuku AA, Willingham AL, Keyyu JD, Phiri IK, Nansen P. Distribution and density of cysticerci of Taenia solium by muscle groups and organs in naturally infected local finished pigs in Tanzania. Veterinary Parasitology. 2002;106: 155–164. doi:10.1016/S0304-4017(02)00037-7 That reported 0 cyst found in entrails. The paper cited in the comment reported 0 cysts in the entrails with the exception of the liver where only 3.7 % of cysts were found. Reviewer response: Thank you, it would be useful for the authors to summarise the above justifications underpinning the assumption around lack of connecting portion allocations from different parts of the pig carcass to variable exposure risk. Comment 8. After review of S1. Fig1. I am not clear where the decision process regarding sale or slaughter of pigs is included within the Household module flow chart. Indeed, it appears this is within the S2 Fig3: Pig module flow chart. Instead, which might cause some confusion when trying to match the description in the methods to these supplemental figures. On a further note, S1 Fig 1 in the S2 word document should be S2 Fig 1? Can the authors check in detail throughout the supplementary to ensure there are no typos such as this please. Authors answer: Thanks for noting that. We corrected accordingly figures S2 Fig1 and S2 Fig3 the pigs and household flow charts. Reviewer response: Thank you for the revision; only minor suggestion would be to make sure the arrow on the line after the box “Designate breeding sow to be killed, replace sow” is before the intersection rather than after (otherwise appears that the decision tree does not continue to the pig selling boxes. Comment 9. How valid is the assumption that “neighbouring areas have similar levels of T. solium transmission” regarding assigning the same probability of cysticercosis for imported pig agents (lines 240-242). Authors answer: Unfortunately, this is only a guess because not studies on prevalence of pigs imported in the study rural villages were made. We then reasonably supposed that if imported from similar rural areas pigs had to present same levels of cysticercosis prevalence. More studies are coming. Reviewer response: Thank you, I would suggest a short section in the discussion (or methods) to state where further studies will address these gaps/ assumptions (similar for the next comment on prevalence of imported pigs, number of distributed pork portions per household member) where the authors indicate more studies are coming. Comment 11. Furthermore, can the explain why pork portions are distributed more widely from the initial household (lines 256-260), are these pork portions sold to the other households, or given freely? If sold, is there a probability associated with the ability to pay for the recipient household, or is this effectively captured in the pigimportRateHousehold parameter (Table 2)? Probabilities in Table 2??? – should they be represented by a prob distribution w/ parameters? Authors answer: We made the assumption, based on direct observations in the field that distribution of pork start always from the members of the household. This is another really interesting topic connecting wealth with exposure to TS infection risk. But unfortunately, again, we have not data to connect ability to pay with actual consume of pork. More studies are coming. The pork portion are given freely in the model without stratifying by household wealth. We explained this point better in the main text. Reviewer response: OK (see above) Minor (methods) comments: Comment 3. The wording in the following sentence could be improved for clarity, and Significative effects should be rephrased to significant effect (line 154): “Data from the 5 intervention villages, in which however, as showed in the original study (10), interventions produced no significative effects on observed HT and PC prevalence, were then used to validate the final calibration process”. Authors answer: OK sentence rephrased to: “Data from the 5 intervention villages of the trial were used to validate the calibration process. As showed in the original study [10], the trial interventions produced no significative effects on observed HT and PC prevalence in those villages and the resulting empirical data can be considered as baseline unperturbed data exactly as the data from the 3 control villages. This makes the 5 intervention villages data the ideal candidate to validate the calibration process.” Reviewer response: Thanks, the wording indicated above differs slightly from the revised wording in the manuscript (lines 170 – 176), please re-check this. Results (pg.27) Comment 11. While the authors highlight that the orders of magnitude are similar for the non-local parameters in the noNecro and simplified setups, which is true (Table 8), I am not convinced by the statement that the “simplified model calibration is able to estimate precisely the calibration parameters” (lines 574 – 575) – while they are not far off, particularly for the pigProglotIn probability there is quite a difference i.e. 3.86 to 11.23, so I think this statement is too strong to make. Are there uncertainty estimates available from the fitting procedure for each parameter, to then assess whether there is overlap in these uncertainty ranges (95% credible intervals) to make the comparison more valid? There is a reference missing on page 574, which might refer to Figure 7, in which case a stronger argument can be made for this statement? Authors answer: Again, this problem of missing tables references. The reviewer is right this missing was a reference to Figure 7. Sorry again about that. The cited sentence “simplified model calibration is able to estimate precisely the calibration parameters” was did not referred to the actual value of the parameter but to the goodness of cross-validation test. We added an explanation to the main text to make this clearer. Reviewer response: Thanks, can the authors include reference to “cross-correlation” in the Fig.7 legend since this is the terminology used on line 639 Comment #: About an uncertainty interval a comparison of parameter pigProglotInf for noNecro in figure 4 and for simplified in figure S3 fig 2 shows that the posterior distributions did not overlap at all so the two parameter estimation are truly different. We see this not as a problem because the model is different in the two setups. We agree that 3.86 is not strictly of the same order of magnitude of 11.23 so we changed the sentence in: “As expected, the calibrated model parametrization for the noNecro and simplified calibration setups (Table 8) are different with more pronounced differences in the values of parameters pHumanCyst and pigProglotInf” Reviewer response: Thanks for this explanation, I think also highlighting the non-overlap with posterior distributions from the simplified calibration step (S3 fig 2) would be useful in the main text. Comment 12. The authors state “The result of the simulations demonstrates that the parametrization obtained from the global calibration procedure presented here can be effectively exported to similar villages without any additional adjustment.” (lines 595 – 594) and while the average RE might similar, the variation in RE (particularly for higher REs) seems greater for the validated results to intervention villages (with max errors of 75% for HT (validated) compared to 45% for HT (calibrated) and 117% for PC (validated) compared to 75% for PC (calibrated)). I think the authors need to caveat the above statement, especially if they are interested in transferring the model to look at individual villages in a different setting. Is there for example a threshold difference in average RE that the authors would then the globally calibrated model would not be transferrable to another endemic setting? Authors answer: We want to observe that the max error for HT validated is 37% and not 75%. That value falls close to the RE of 45% for the calibration. We agree with the reviewer about the fact that more quantitative criteria would be useful to discriminate among good and bad calibrations. Unfortunately, this would be possible only if we were able to estimate uncertainties of empirical data. With empirical data uncertainties it would be possible to say if a calibrated model parametrization is producing or not outcome in agreement with observed data. We are drafting a paper were pig seroprevalence is used as summary statistics and empirical data uncertainties on the observed data will make a mor quantitative criteria about model transferability available. Reviewer response: Thanks for the further details. I am unclear why the max relative error is 37% (from village 510) rather than the RE from village 568 of 75% in table 9 to support the statement above. And is the average RE value of 45% for HT (for the control villages) calculated from Table 7? There is also a typo in line 656 (transferred to transferred) Reviewer #2: The authors have made great improvement in this paper. Further, all comments and suggestions from all reviewers were addressed accordingly. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Non-local validated parametrization of an agent-based model of local-scale Taenia solium transmission in North-West Peru PONE-D-21-27051R2 Dear Dr. Pizzitutti, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marcello Otake Sato, Ph.D., D.V.M. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-21-27051R2 Non-local validated parametrization of an agent-based model of local-scale Taenia solium transmission in North-West Peru Dear Dr. Pizzitutti: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marcello Otake Sato Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .